Page 2,124«..1020..2,1232,1242,1252,126..2,1302,140..»

Stem Cells Of Infertile Men Used To Create Preliminary Sperm Cells

Posted: May 3, 2014 at 12:51 pm

April Flowers for redOrbit.com Your Universe Online

A new study, from the Stanford University School of Medicine and Montana State University, demonstrates that, when implanted into the reproductive system of a mouse model, stem cells created from adult, infertile men will yield primordial germ cells. Primordial germ cells normally become sperm cells.

The findings, published in Cell Reports, help to further our understanding of a genetic cause of male infertility and basic sperm biology. The research team says that their approach holds considerable potential for clinical applications.

All of the infertile male participants suffer from a genetic mutation that prevents their bodies from producing mature sperm. The study suggests that the men with this condition called azoospermia might have produced germ cells at some point in their early lives, but these cells were lost as the men matured to adulthood.

Our results are the first to offer an experimental model to study sperm development, said Renee Reijo Pera of the Institute for Stem Cell Biology & Regenerative Medicine and Montana State University. Therefore, there is potential for applications to cell-based therapies in the clinic, for example, for the generation of higher quality and numbers of sperm in a dish.

It might even be possible to transplant stem-cell-derived germ cells directly into the testes of men with problems producing sperm, she added. Considerable study to ensure safety and practicality is needed, however, before reaching that point.

Infertility is a fairly common problem, affecting between 10 and 15 percent of couples in the US. The researchers say that many men are affected by genetic causes of infertility, most commonly due to the spontaneous loss of key genes on the Y sex chromosome. Until now, the causes of infertility at the molecular level have not been clear.

The fact that the research team was able to create primordial germ cells from the infertile men is very promising, but they note that these stem cells created far fewer of these sperm progenitors than the stem cells of men without the genetic mutations. They are sure, however, that this research provides a much needed model to study the earliest steps of human reproduction.

We saw better germ-cell differentiation in this transplantation model than weve ever seen, said Reijo Pera, former director of Stanfords Center for Human Embryonic Stem Cell Research and Education. We were amazed by the efficiency. Our dream is to use this model to make a genetic map of human germ-cell differentiation, including some of the very earliest stages.

Humans share many cellular and physiological processes with common laboratory animals such as mice or fruit flies. In reproduction, however, there are significant variances, making it challenging to recreate the human reproductive processes in a laboratory setting. In addition, many crucial steps, such as the development and migration of primordial germ cells to the gonads,occur in the relatively short first days or weeks after conception.

Read the original post:
Stem Cells Of Infertile Men Used To Create Preliminary Sperm Cells

Posted in Cell Medicine | Comments Off on Stem Cells Of Infertile Men Used To Create Preliminary Sperm Cells

Stem Cell Therapy Market (Autologous & Allogeneic) Worth $330 Million in 2020 – New Report by MarketsandMarkets

Posted: May 3, 2014 at 12:49 pm

(PRWEB) May 02, 2014

The report Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020 analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World (RoW).

Browse 57 market data tables 32 figures spread through 196 Slides and in-depth TOC on Stem Cell Therapy Market http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html

Early buyers will receive 10% customization on report.

This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020.

Download Free PDF Download @ http://www.marketsandmarkets.com/pdfdownload.asp?id=48

The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. In addition, based on the therapeutic applications, the global stem cell therapy market is segmented into eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS diseases, CVS diseases, wounds and injuries, and others.

Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=48

A number of factors such as the increasing funding from various government and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are stimulating the research activities for stem cell therapies. Developing markets, emergence of induced pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs), and evolution of new stem cell therapies represent high growth opportunities for market players.

In 2015, North America will hold the largest share of the global stem cell therapy market. This large share is primarily attributed to the extensive government funding and increasing fast-track approval for stem cell therapeutics by the FDA. Moreover, development of advanced genomic methods for stem cell analysis and high number of ongoing research activities are further fueling the growth of the stem cell therapy market in North America. However, the Asia-Pacific stem cell therapy market is expected to grow at the highest CAGR in the forecast period, owing to factors such as increasing regulatory support through favorable government policies, strong product pipelines, and increasing licensing activities in this region.

Go here to read the rest:
Stem Cell Therapy Market (Autologous & Allogeneic) Worth $330 Million in 2020 - New Report by MarketsandMarkets

Posted in Cell Therapy | Comments Off on Stem Cell Therapy Market (Autologous & Allogeneic) Worth $330 Million in 2020 – New Report by MarketsandMarkets

Stem Therapy May Improve Survival of Heart Patients

Posted: May 3, 2014 at 12:49 pm

A new review of previous scientific studies has concluded that stem cell therapy may help reduce the number of deaths in heart patients.

The Cochrane Heart Review Group analyzed data from studies involving just over 1,200 patients in 23 randomized, controlled trials.

The group's report on the potential benefits of stem cell heart repair was published online on April 29 in The Cochrane Library. The Cochrane Reviews are systematic assessments of evidence-based research into human health care and health policy.

There were fewer deaths among heart patients receiving stem cell therapy in addition to standard treatment, compared to patients who were treated with traditional therapies alone or with a placebo. Stem cells are primitive master cells that, under the right conditions, can turn into any cell in the body.

The therapy also reduced the chances that patients, with improved heart function, had to be readmitted to the hospital.

The review noted that stem cell therapy could possibly reduce the number of deaths after one year, but the results of larger clinical trials are needed.

The stem cells are taken from a patients own bone marrow and injected into the hearts of patients with ischemic heart disease and congestive heart failure, repairing damaged cardiac tissue.

Dr. Enca Martin-Rendon, author of the review in Britain, said, This is encouraging evidence that stem cell therapy has benefits for heart disease patients. However, Martin-Rendon noted it is difficult to come to any concrete conclusions until larger clinical trials are carried out.

Read the original post:
Stem Therapy May Improve Survival of Heart Patients

Posted in Cell Therapy | Comments Off on Stem Therapy May Improve Survival of Heart Patients

Vivian & Ashley EC #1: Stem Cells – Video

Posted: May 3, 2014 at 4:53 am


Vivian Ashley EC #1: Stem Cells
By Vivian Lee Ashley Hong BIO362 Developmental Biology Spring 2014.

By: devo_videos

More here:
Vivian & Ashley EC #1: Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on Vivian & Ashley EC #1: Stem Cells – Video

Stem Cell Research & Human Dignity – Video

Posted: May 3, 2014 at 4:53 am


Stem Cell Research Human Dignity
A preview of Moral Compass : Stem Cell Research Human Dignity This is a free preview of the full episode; to see the full version, sign up for a Premium ac...

By: ChurchMilitantTV

View post:
Stem Cell Research & Human Dignity - Video

Posted in Stem Cell Research | Comments Off on Stem Cell Research & Human Dignity – Video

Stem Cell Research Public Service Announcement – Video

Posted: May 3, 2014 at 4:53 am


Stem Cell Research Public Service Announcement
Digital PSA for University of Kentucky #39;s WRD111 Course. Songs: Fix You - Coldplay Beautiful Day - U2 (used without permission) Works Cited "Neuralstem Cell T...

By: Kirstie Kleiner

Continue reading here:
Stem Cell Research Public Service Announcement - Video

Posted in Stem Cell Research | Comments Off on Stem Cell Research Public Service Announcement – Video

Stem Cell Research Period 2 – Video

Posted: May 3, 2014 at 4:53 am


Stem Cell Research Period 2
Biology.

By: Abby7674

Continued here:
Stem Cell Research Period 2 - Video

Posted in Stem Cell Research | Comments Off on Stem Cell Research Period 2 – Video

Stem cell cloning may be aid treatment for diabetes – CBS News

Posted: May 2, 2014 at 10:40 pm

Scientists have moved one step closer to creating and effective diabetes treatment by creating insulin-producing cells with the DNA of a diabetic woman.

The approach could someday aid treatment of the Type 1 form of the illness, which is usually diagnosed in childhood and accounts for about 5 percent of diabetes cases in the U.S. The disease kills insulin-making cells in the pancreas. People with Type 1 diabetes use shots or a small pump to supply the hormone, which is needed to control blood sugar.

The new work is a step toward providing genetically matched replacement cells for transplant, said Dieter Egli of the New York Stem Cell Foundation Research Institute in New York. He led the research, which was reported online Monday in the journal Nature.

Doug Melton of the Harvard Stem Cell Institute, who was not involved with the work, called the paper an impressive technical achievement. But he said he believed the cells would be useful as a research tool rather than a source of transplants. They could help scientists uncover what triggers Type 1 diabetes, he said, which could in turn lead to better therapies.

Scientists had previously made insulin cells that match diabetic patients by another means, so the new work gives researchers another option for comparison. Researchers are also exploring transplants of insulin-producing cells from cadavers as a potential treatment.

The latest work used a technique that partially resembles the process used to clone animals. Basically, scientists put DNA from the woman's skin cells into donated human eggs. The eggs were grown into early embryos. From these, the scientists removed stem cells, which can grow into any cell type in the body. These stem cells were turned into the insulin-producing cells.

Egli told reporters that these cells have shown promise in animal tests, but that he could not estimate a timetable for human experiments. The new work is the third report of using the cloning approach to make human stem cells, and the first using the technique to create insulin-making cells.

Stem cells cloning is an area of research that's showing promise to treat a number of diseases. In January, Dr. Jon LaPook, chief medical correspondent for CBS News, reported an experimental stem cell treatment for patients with multiple sclerosis. Scientists have also been able to repair bones using the stem cells of fatty tissue and also use cloned cells can repair a damaged heart.

Read more:
Stem cell cloning may be aid treatment for diabetes - CBS News

Posted in Stem Cell Therapy | Comments Off on Stem cell cloning may be aid treatment for diabetes – CBS News

Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New …

Posted: May 2, 2014 at 10:40 pm

New York, NY (PRWEB) May 02, 2014

Stem Cell Institute is releasing additional tickets for its Adult Stem Cell Therapy Clinical Trials seminar on Saturday, May 17, 2014 in New York City at the New York Hilton Midtown from 1:00 pm to 4:00 pm.

After booking its original meeting room beyond capacity, the Stem Cell Institute has reserved a larger room to accommodate additional attendees. The seminar will now take place in the Beekman Room, 2nd Floor, East Corridor of the New York Hilton Midtown.

Those interested in attending are encouraged to register promptly. Only 75 additional seats are available.

Speakers include:

Neil Riordan PhD Clinical Trials: Umbilical Cord Mesenchymal Stem Cell Therapy for Autism and Spinal Cord Injury

Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc.

Jorge Paz-Rodriguez MD Stem Cell Therapy for Autoimmune Disease: MS, Rheumatoid Arthritis and Lupus

Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama.

Special guest speaker:

Read more:
Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New ...

Posted in Stem Cell Therapy | Comments Off on Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New …

MS Life 2014 – Research Talks – Stem Cells – Video

Posted: May 2, 2014 at 9:46 am


MS Life 2014 - Research Talks - Stem Cells

By: MS Society

Read the rest here:
MS Life 2014 - Research Talks - Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on MS Life 2014 – Research Talks – Stem Cells – Video

Page 2,124«..1020..2,1232,1242,1252,126..2,1302,140..»